The Company has completed the transfer of 93,577 shares of BACC Health Care Private Limited to Inviga Healthcare Fund I and its nominee (the Buyer) on June 29, 2026.
This represents approximately 99.999% of the total 93,578 shares held by HCG in BACC.
The transaction was executed pursuant to the Share Purchase Agreement (SPA) dated May 19, 2026, which was previously approved by HCG's Board of Directors on the same date.
The transfer of 1 remaining share held by a nominee on behalf of the Company is currently under process.
Financial Consideration
Total consideration for the entire shareholding is ₹37,64,44,788 (Indian Rupees Thirty-Seven Crores Sixty-Four Lakhs Forty-Four Thousand Seven Hundred and Eighty-Eight Only).
Initial consideration of ₹28,23,33,591 (Indian Rupees Twenty-Eight Crores Twenty-Three Lakhs Thirty-Three Thousand Five Hundred and Ninety-One Only) was received on June 29, 2026.
Deferred consideration of ₹9,41,11,197 constitutes the balance amount, payable within 18 months from the SPA signing date (May 19, 2026).
The deferred consideration is explicitly stated as being only time-deferred and not conditional or contingent.
